These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. Tanikawa T; Okada Y; Tanikawa R; Tanaka Y J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577 [TBL] [Abstract][Full Text] [Related]
4. PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. Heit B; Liu L; Colarusso P; Puri KD; Kubes P J Cell Sci; 2008 Jan; 121(Pt 2):205-14. PubMed ID: 18187452 [TBL] [Abstract][Full Text] [Related]
5. In vitro glycoxidation alters the interactions between collagens and human polymorphonuclear leucocytes. Monboisse JC; Rittie L; Lamfarraj H; Garnotel R; Gillery P Biochem J; 2000 Sep; 350 Pt 3(Pt 3):777-83. PubMed ID: 10970792 [TBL] [Abstract][Full Text] [Related]
6. Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Montecucco F; Bianchi G; Gnerre P; Bertolotto M; Dallegri F; Ottonello L Ann N Y Acad Sci; 2006 Jun; 1069():463-71. PubMed ID: 16855174 [TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products subspecies-selectively induce adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. Takahashi HK; Mori S; Wake H; Liu K; Yoshino T; Ohashi K; Tanaka N; Shikata K; Makino H; Nishibori M J Pharmacol Exp Ther; 2009 Jul; 330(1):89-98. PubMed ID: 19380603 [TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure. Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075 [TBL] [Abstract][Full Text] [Related]
9. Enhanced neutrophil motility by granulocyte colony-stimulating factor: the role of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. Nakamae-Akahori M; Kato T; Masuda S; Sakamoto E; Kutsuna H; Hato F; Nishizawa Y; Hino M; Kitagawa S Immunology; 2006 Nov; 119(3):393-403. PubMed ID: 16903868 [TBL] [Abstract][Full Text] [Related]
10. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826 [TBL] [Abstract][Full Text] [Related]
11. Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. McCarthy AD; Uemura T; Etcheverry SB; Cortizo AM Int J Biochem Cell Biol; 2004 May; 36(5):840-8. PubMed ID: 15006636 [TBL] [Abstract][Full Text] [Related]
12. Effects of extracellular matrix glycosylation on proliferation and apoptosis of human dermal fibroblasts via the receptor for advanced glycosylated end products. Niu Y; Xie T; Ge K; Lin Y; Lu S Am J Dermatopathol; 2008 Aug; 30(4):344-51. PubMed ID: 18645306 [TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. Chen Q; Dong L; Wang L; Kang L; Xu B Biochem Biophys Res Commun; 2009 Apr; 381(2):192-7. PubMed ID: 19232321 [TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products: sparking the development of diabetic vascular injury. Goldin A; Beckman JA; Schmidt AM; Creager MA Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049 [TBL] [Abstract][Full Text] [Related]
15. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis. Susa Y; Masuda Y; Imaizumi H; Namiki A Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040 [TBL] [Abstract][Full Text] [Related]
16. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2. Binet F; Girard D J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151 [TBL] [Abstract][Full Text] [Related]
17. Migration of keratinocytes is impaired on glycated collagen I. Morita K; Urabe K; Moroi Y; Koga T; Nagai R; Horiuchi S; Furue M Wound Repair Regen; 2005; 13(1):93-101. PubMed ID: 15659041 [TBL] [Abstract][Full Text] [Related]